Levnibiot

Levofloxacin, the active ingredient in Levnibiot, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats bacterial infections of the respiratory, urinary, skin and related systems in adult patients. GNH USA supplies Levnibiot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is indicated for bacterial infections affecting several organ systems. - Respiratory tract infections: eradicates the causative bacteria and improves breathing symptoms. - Urinary tract infections: eliminates urinary pathogens and relieves dysuria. - Skin and soft‑tissue infections: clears bacterial invasion of skin, reducing inflammation. - Sinusitis: resolves sinus bacterial colonisation and restores sinus drainage. - Prostatitis: treats bacterial prostatitis, alleviating pelvic discomfort.

Levofloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: increased bowel movements, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or unsteadiness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function in tendons, especially the Achilles. - QT interval prolongation: cardiac rhythm disturbances that may cause palpitations. - Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention.

Levofloxacin should be used with caution in specific clinical situations. - Renal function assessment: adjust use in patients with impaired kidney function. - Tendon disorder avoidance: do not use in individuals with a history of tendon disease. - Cardiac monitoring: avoid in patients with known QT‑prolongation risk. - Hypersensitivity vigilance: discontinue if signs of allergic reaction appear. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levofloxacin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of toxicity. - NSAIDs (e.g., ibuprofen, naproxen): heightened central nervous system adverse effects. - Antacids containing magnesium or aluminum: reduced levofloxacin absorption.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Cyclosporine: increased cyclosporine plasma levels, watch for nephrotoxicity. - Oral hypoglycemic agents: possible alteration of blood glucose control.